Manufacturer of Controlled Substances; Notice of Registration, 81979-81980 [2011-33404]

Download as PDF Federal Register / Vol. 76, No. 250 / Thursday, December 29, 2011 / Notices 40 FR 43745–46, all applicants for registration to import a basic class of any controlled substance in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Dated: December 22, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. States. The company is aware of the requirement to obtain a DEA registration as an exporter to conduct this activity. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than February 27, 2012. Dated: December 20, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–33402 Filed 12–28–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE 81979 of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: December 20, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–33400 Filed 12–28–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [FR Doc. 2011–33421 Filed 12–28–11; 8:45 am] Manufacturer of Controlled Substances; Notice of Registration Drug Enforcement Administration BILLING CODE 4410–09–P Manufacturer of Controlled Substances; Notice of Application DEPARTMENT OF JUSTICE Pursuant to § 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on October 10, 2011, Norac Inc., 405 S. Motor Avenue, Azusa, California 91702–3232, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule wreier-aviles on DSK3TPTVN1PROD with NOTICES Gamma Hydroxybutyric Acid (2010). Tetrahydrocannabinols (7370) ..... Methamphetamine (1105) ............ Pentobarbital (2270) ..................... Nabilone (7379) ............................ I I II II II 15:12 Dec 28, 2011 Jkt 226001 Manufacturer of Controlled Substances; Notice of Registration By Notice dated May 25, 2011, and published in the Federal Register on June 3, 2011, 76 FR 32225, AMPAC Fine Chemicals LLC., Highway 50 and Hazel Avenue Building 05011, Rancho Cordova, California 95670, made application to the Drug Enforcement Administration (DEA) as a bulk manufacturer of the following basic classes of controlled substances: Drug Schedule Thebaine (9333) ........................... Poppy Straw Concentrate (9670) With regard to Gamma Hydroxybutyric Acid (2010), Tetrahydrocannabinols (7370), and Methamphetamine (1105) only, the company manufactures these controlled substances in bulk solely for distribution within the United States to customers engaged in dosage-form manufacturing. With regard to Nabilone (7379), the company presently manufactures a small amount of this controlled substance in bulk solely to conduct manufacturing internal process development. It is the company’s intention that, when the manufacturing process is refined to the point that its Nabilone bulk product is available for commercial use, the company will export the controlled substance in bulk solely to customers engaged in dosageform manufacturing outside the United VerDate Mar<15>2010 Drug Enforcement Administration II II The company is a contract manufacturer. In reference to Poppy Straw Concentrate the company will manufacture Thebaine intermediates for sale to its customers for further manufacture. No other activity for this drug code is authorized for registration. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of AMPAC Fine Chemicals LLC., to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated AMPAC Fine Chemicals LLC., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 By Notice dated September 9, 2011, and published in the Federal Register on September 15, 2011, 76 FR 57080, Chemic Laboratories, Inc., 480 Neponset Street, Building 7, Canton, Massachusetts 02021, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Cocaine (9041), a basic class of controlled substance listed in schedule II. The company plans to manufacture small quantities of the above listed controlled substance for distribution to its customers for the purpose of research. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Chemic Laboratories, to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Chemic Laboratories to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. E:\FR\FM\29DEN1.SGM 29DEN1 81980 Federal Register / Vol. 76, No. 250 / Thursday, December 29, 2011 / Notices Dated: December 20, 2011. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2011–33404 Filed 12–28–11; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Parole Commission Sunshine Act Meeting; Record of Vote of Meeting Closure (Pub. L. 94–409) (5 U.S.C. 552b) I, Isaac Fulwood, of the United States Parole Commission, was present at a meeting of said Commission, which started at approximately 11 a.m., on Thursday, December 8, 2011, at the U.S. Parole Commission, 90 K Street NE., Third Floor, Washington, DC 20530. The purpose of the meeting was to discuss four original jurisdiction cases pursuant to 28 CFR 2.27. Four Commissioners were present, constituting a quorum when the vote to close the meeting was submitted. Public announcement further describing the subject matter of the meeting and certifications of the General Counsel that this meeting may be closed by votes of the Commissioners present were submitted to the Commissioners prior to the conduct of any other business. Upon motion duly made, seconded, and carried, the following Commissioners voted that the meeting be closed: Isaac Fulwood, Cranston J. Mitchell, Patricia Cushwa and J. Patricia Wilson Smoot. In witness whereof, I make this official record of the vote taken to close this meeting and authorize this record to be made available to the public. Dated: December 13, 2011. Isaac Fulwood, Chairman, U.S. Parole Commission. [FR Doc. 2011–33524 Filed 12–27–11; 4:15 pm] BILLING CODE 4410–01–P DEPARTMENT OF LABOR wreier-aviles on DSK3TPTVN1PROD with NOTICES Office of the Secretary Agency Information Collection Activities; Submission for OMB Review; Comment Request; Green Jobs and Health Care Impact Evaluation of ARRA-Funded Grants ACTION: Notice. The Department of Labor (DOL) is submitting the Employment and Training Administration (ETA) SUMMARY: VerDate Mar<15>2010 15:12 Dec 28, 2011 Jkt 226001 sponsored information collection request (ICR) titled, ‘‘Green Jobs and Health Care Impact Evaluation of ARRA-funded Grants,’’ to the Office of Management and Budget (OMB) for review and approval for continued use in accordance with the Paperwork Reduction Act (PRA) of 1995 (44 U.S.C. 3501 et seq.). DATES: Submit comments on or before January 30, 2012. ADDRESSES: A copy of this ICR with applicable supporting documentation; including a description of the likely respondents, proposed frequency of response, and estimated total burden may be obtained from the RegInfo.gov Web site, https://www.reginfo.gov/ public/do/PRAMain, on the day following publication of this notice or by contacting Michel Smyth by telephone at (202) 693–4129 (this is not a toll-free number) or sending an email to DOL_PRA_PUBLIC@dol.gov. Submit comments about this request to the Office of Information and Regulatory Affairs, Attn: OMB Desk Officer for the Department of Labor, Employment and Training Administration (ETA), Office of Management and Budget, Room 10235, Washington, DC 20503, Telephone: (202) 395–6929/Fax: (202) 395–6881 (these are not toll-free numbers), email: OIRA_submission@omb.eop.gov. FOR FURTHER INFORMATION: Contact Michel Smyth by telephone at (202) 693–4129 (this is not a toll-free number) or by email at DOL_PRA_PUBLIC@dol.gov. SUPPLEMENTARY INFORMATION: ETA is undertaking the Green Jobs and Health Care Impact Evaluation of the Pathways Out of Poverty (POP—Green Jobs) and Health Care and High Growth Training grant initiatives. The goal of this evaluation is to determine the extent to which enrollees achieve increases in employment, earnings, and career advancement as a result of their participation in the training provided by Pathways and Health Care grantees and to identify promising best practices and strategies for replication. This information collection is subject to the PRA. A Federal agency generally cannot conduct or sponsor a collection of information, and the public is generally not required to respond to an information collection, unless it is approved by the OMB under the PRA and displays a currently valid OMB Control Number. In addition, notwithstanding any other provisions of law, no person shall generally be subject to penalty for failing to comply with a collection of information if the collection of information does not PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 display a valid OMB Control Number. See 5 CFR 1320.5(a) and 1320.6. The DOL obtains OMB approval for this information collection under OMB Control Number 1205–0481. The current OMB approval is scheduled to expire on January 31, 2012; however, it should be noted that existing information collection requirements submitted to the OMB receive a month-to-month extension while they undergo review. For additional information, see the related notice published in the Federal Register on September 28, 2011 (76 FR 60084). Interested parties are encouraged to send comments to the OMB, Office of Information and Regulatory Affairs at the address shown in the ADDRESSES section within 30 days of publication of this notice in the Federal Register. In order to help ensure appropriate consideration, comments should reference OMB Control Number 1205– 0481. The OMB is particularly interested in comments that: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Agency: Employment and Training Administration (ETA). Title of Collection: Green Jobs and Health Care Impact Evaluation of ARRA-funded Grants. OMB Control Number: 1205–0481. Affected Public: Individuals or households; State, Local, and Tribal Governments. Total Estimated Number of Respondents: 6,024. Total Estimated Number of Responses: 12,000. Total Estimated Annual Burden Hours: 2,600. Total Estimated Annual Other Costs Burden: $0. E:\FR\FM\29DEN1.SGM 29DEN1

Agencies

[Federal Register Volume 76, Number 250 (Thursday, December 29, 2011)]
[Notices]
[Pages 81979-81980]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-33404]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated September 9, 2011, and published in the Federal 
Register on September 15, 2011, 76 FR 57080, Chemic Laboratories, Inc., 
480 Neponset Street, Building 7, Canton, Massachusetts 02021, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of Cocaine (9041), a basic class 
of controlled substance listed in schedule II.
    The company plans to manufacture small quantities of the above 
listed controlled substance for distribution to its customers for the 
purpose of research.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Chemic Laboratories, to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has investigated Chemic Laboratories to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance 
with 21 CFR 1301.33, the above named company is granted registration as 
a bulk manufacturer of the basic class of controlled substance listed.


[[Page 81980]]


    Dated: December 20, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-33404 Filed 12-28-11; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.